📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A RANKL mutant used as an inter-species vaccine for efficient immunotherapy of osteoporosis. (2015)

First Author: Liu C

Attributed to: Structural Studies on Viruses, Viral Proteins and Cell Interactions funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/srep14150

PubMed Identifier: 26412210

Publication URI: http://europepmc.org/abstract/MED/26412210

Type: Journal Article/Review

Volume: 5

Parent Publication: Scientific reports

ISSN: 2045-2322